title: [The authorized considerations on the pre-clinical study of drug-eluting coronary stent system].
abstract: China Food and Drug Administration didn't issue any guideline on the pre-clinical study of drug-eluting coronary stent system, the basic requirement of the authorized administration was summarized to help manufacture prepare the document during the registration process.
authors.forename: Maobo
authors.initials: M
authors.lastname: Cheng
authors.forename: Xinli
authors.initials: X
authors.lastname: Shi
authors.forename: Jianxiong
authors.initials: J
authors.lastname: Jia
authors.forename: Jingjing
authors.initials: J
authors.lastname: Miao
authors.forename: Wei
authors.initials: W
authors.lastname: Liu
authors.forename: Feilong
authors.initials: F
authors.lastname: Nie
mesh_terms: D002681:China; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D054855:Drug-Eluting Stents; D017408:Guidelines as Topic